Androgen-receptor gene structure and function in prostate cancer

World Journal of Urology

Volumn 14, Issue 5, 1996, Pages 329-337

  Hakimi, J M ^a   Rondinelli, R H ^a   Schoenberg, M P ^a   Barrack, E R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; TUMOR MARKER;

ALLELE; CELL DIVISION; CHEMISTRY; DNA PROBE; GENETICS; HUMAN; MALE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVIEW;

ALLELES; CELL DIVISION; DNA PROBES; HUMANS; MALE; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0030334209     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00184606     Document Type: Article

References (46)

1. Brendler CB, Follansbee AL, Isaacs JT (1985) Discrimination between normal, hyperplastic and malignant human prostatic tissues by enzymatic profiles. J Urol 133:495-501
2. Bussemakers MJG, Bova GS, Schoenberg MP, Hakimi JM. Barrack ER, Isaacs WB (1994) Microsatellite instability in human prostate cancer. J Urol 151 :469A
3. Carter HB, Piantadosi S, Isaacs JT (1990) Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 143:742-746
4. Castagnaro M, Yandell DW, Dockhorn-Dworniczak B, Wolfe HJ, Poremba C (1993) Human androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer. Verh Dtsch Ges Pathol 77: 119-123
5. Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
6. Cheng J, Haas M (1992) Sensitivity of detection of heterozygous point mutations in p53 cDNAs by direct PCR sequencing. PCR Methods Appl 1 :199-201
7. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H (1993) Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541-1550
8. Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV, Bartsch G (1993): DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22:11-22
9. Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS (1982) A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J Urol 128:729-734
10. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R ( 1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12: 241-253
11. Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O, Vikho P (1995) Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 80:3494-3500
12. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn 1A, Finger MJ, Moul JW, Srivastava S (1994) Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancer. Cancer Res 54:2861-2864
13. Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai YC, Spruck CH III, Miyao N, Nichols PW, Hermann GG, Horn T, Steven K, Summerhayes IC, Sidransky D. Jones PA (1993) Microsatellite instability in bladder cancer. Cancer Res 53:56205623
14. Greenblatt MS, Benne WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:48554878
15. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266:1821-1828
16. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA (1980) The LNCaP cell line - a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115132
17. Irvine RA, Yu MC, Ross RK, Coetzee G A (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937-1940
18. Kazemi-Esfarjani P. Trifiro MA, Pinsky L (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4:523-527
19. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in Xlinked spinal and bulbar muscular atrophy. Nature 352:77-79
20. Loeb LA (1994) Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54:5059-5063
21. Lubahn DB, Joseph DR, Sar M, Tan J-A, Higgs HN, Larson RE, French FS, Wilson EM (1988) The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2 : 1265-1275
22. Macke JP, Hu N, Hu S, Bailey M, King VL, Brown T, Harrier D, Nathans J (1993) Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation. Am J Hum Genet 53:844-852
23. Martin JB (1993) Molecular genetics of neurological diseases. Science 262:674-676
24. Nastiuk KL, Clayton DF (1994) Seasonal and tissue-specific regulation of canary androgen receptor messenger ribonucleic acid. Endocrinology 134:640-649
25. Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER (1992) Androgen receptor gene mutations in prostate cancer. Proc NatI Acad Sei USA 89 : 6319-6323
26. Peterziel H, Culig Z, Stober J, Hobisch A, Radmayr C, Bartsch G, Klocker H, Cato ACB (1995) Mutant androgen receptors in prostatic tumors distinguish between amino acid requirements for transactivation and ligand binding. Int J Cancer 63:544-550
27. Quigley ÇA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:272321
28. Ris-Stalpers C, Verleun-Mooijman MCT, Trapman J, Brinkmann AO (1993) Threonine on amino acid position 868 in the human androgen receptor is essential for androgen binding specificity and functional activity. Biochem Biophys Res Commun 196:173-180
29. Ross RK, Paganini-Hill A, Henderson BE (1983) The etiology of prostate cancer: what does the epidemiology suggest? Prostate 4:333-344
30. Ruizeveld de Winter JA, Janssen JA, Sleddens HMEB, Verleun-Mooijman MCT, Trapman J, Brinkmann AO, Santerse AB, Schröder FH, Kwast TH van der (1994) Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144:735-746
31. Sadi MV, Barrack ER (1993) Image analysis of androgen receptor immunostaining in metastatic prostate cancer: heterogeneity as a predictor of response to hormonal therapy. Cancer 71:2574-2580
32. Scher HI, Kelly WK (1993) Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer. J Clin Oncol 11:1566-1572
33. Schoenberg MP, Tonb DC, Brown TR, Barrack ER (1993) Functional analysis of an androgen receptor gene mutation in localized human prostate cancer (abstract). Proceedings, 7th annual meeting of the Society for Basic Urologie Research, San Antonio, Texas, May 14-15
34. Schoenberg MP, Hakimi JM, Wang S, Bova OS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC, Barrack ER (1994) Microsatellite mutation (CAG24->i8) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 198: 74-80
35. Silver RI, Wiley EL, Davis DL, Thigpen AE, Russell DW, McConnell JD (1994) Expression and regulation of steroid 5oc-reductase 2 in prostate disease. J Urol 152:4334-37
36. Silver RI, Wiley EL, Thigpen AE, Guileyardo JM, McConnell JD, Russell DW (1994) Cell type specific expression of steroid 5a-reductase 2. J Urol 152:438-442
37. Sleddens HFBM, Oosira BA, Brinkmann AO, Trapman J (1993) Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet 2:493
38. Sobue G, Doyu M, Morishima T, Mukai E, Yasuda T, Kachi T, Mitsuma T (1994) Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuronopathy. J Neurol Sei 121:167-171
39. Suzuki H. Sato N, Watabe Y, Masai M, Seino S, Shimazaki J (1993) Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46:759-765
40. Takahashi H, Furusato M, Allsbrook WC Jr, Nishii H, Wakui S, Barrett JC, Boyd J ( 1995) Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Res 55: 1621-1624
41. Taplin M-E, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393-1398
42. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
43. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnel! DP (1993) Human progesterone receptor A form is a cell- and promoter-specific represser of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
44. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E (1992) Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat shock protein interactions, and transcriptional activation. Biochemistry 31:2393-2399
45. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9:4014106
46. Wilding G (1992) The importance of steroid hormones in prostate cancer. Cancer Surv 14: 113-130